Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital
Washington University School of Medicine · NCT07146568
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 20+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 5515
- US sites recruiting
- 1
- Study start
- February 23, 2026
- Record last updated
- August 12, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Inspired by the ongoing Pink \& Pearl Campaign, the breast radiology service of Christian Hospital in north St. Louis County will partner with Siteman Cancer Center to pilot this campaign in its mammography clinics in order to promote awareness, referral, and completion of lung cancer screening (LCS) among eligible women. This campaign leverages established infrastructure such as nurse navigation and referral to screening or primary care for further shared decision-making on cancer screening. The purpose of this study is to evaluate the effectiveness of the Pink \& Pearl Campaign in improving LCS uptake among LCS-eligible women undergoing mammography at Christian Hospital. This evaluation is grounded in the Integrated Screening Action Model that depicts individual- and environmental-level influences on the screening behavior process. Using an explanatory sequential mixed methods design, which combines both quantitative and qualitative approaches, our specific aims for this proposal are to: a) assess whether the Pink \& Pearl Campaign increases referrals and uptake/completion of LCS among LCS-eligible women undergoing screening mammography; b) determine median time-to-screening after referral to LCS; and c) evaluate individual and health system factors influencing LCS uptake and implementation outcomes of the campaign. These implementation outcomes will help identify whether the campaign was put in place successfully or not. This proposal will inform strategies for integrating cancer screening programs to improve poorly performing programs like LCS.
Being studied: Pink and Pearl Campaign
Conditions: Lung Cancer; Cancer of the Lung
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Eligibility Criteria - Interventional Study
- Undergoing screening mammography at Christian Hospital
- Between the ages of 50-80 years (inclusive)
Eligibility Criteria - Survey and Interview Sub-Studies
- Part of the interventional study
- Reporting a 20 pack-year equivalent of either current smoking history or have quit in the past 15 years
- Can speak and understand English
- Not diagnosed with a serious health problem that will limit life expectancy (such as previous history of lung cancer, symptoms of lung cancer such as hemoptysis or unexplained weight loss of more than 6.8 kg (15 lb) in the previous year)
- Willing and able to get treatment if lung cancer is found
- Able to understand and willing to sign an IRB-approved written informed consent document
Eligibility Criteria - Providers
- At least 20 years of age
- Involved in the breast radiology service or referred at least one patient to the Pink \& Pearl Campaign
- Able to provide verbal consent to participate in the interview
Recruiting US locations
Barnes-Jewish Christian Hospital
St Louis, MO 63136
Site contact: Beryne Odeny, M.D. MPH, Ph.D. · 314-362-1183 · beryne@wustl.edu
Study contacts (from the official record)
- Beryne Odeny, M.D., MPH, Ph.D. · 314-362-1183 · beryne@wustl.edu
- Michelle V Lee, M.D. · 314-454-7405 · lee.michelle@wustl.edu
Similar studies in Missouri
All smoking & vaping studies in Missouri →- RecruitingHealthy volunteers
A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers
RAI Services Company
- Location
- St Louis, MO + 6 other US sites
- Eligibility basics
- Ages 21–65
- RecruitingPhase 3
Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)
Axsome Therapeutics, Inc.
- Location
- Kansas City, MO + 24 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
Eli Lilly and Company
- Location
- St Louis, MO + 16 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteers
The Impact of Menthol Flavoring on Switching in Adult Menthol Smokers
Nikki Nollen, PhD, MA
- Location
- Kansas City, MO
- Eligibility basics
- Ages 21+